FROM Paul Howard
Does Obamacare have a future after all? For six years, Republicans in Congress have voted to repeal and replace the Affordable Care Act, long dubbed "Obamacare." Now, with majorities in both Houses and Donald Trump in the White House, the process is beginning today. But in both houses, the GOP is divided. One side worries that supporters of President Trump may be among the millions who lose health insurance. The other says the new plan doesn't go far enough and complain its toughest provisions won’t take effect until 2020. They call it "Obamacare Light." Nobody knows the possible cost yet — and, as we hear, politics will be more important than substance.
America's Wild West of Drug Pricing Earlier this year, when pharma exec Martin Shkreli bought the rights to an old drug and then raised its price 5000%, Americans named him the most hated man in the country. But he is only doing what Big Pharma does everyday thanks to patent laws and America's free market approach to drug pricing. Rising costs are outraging patients, doctors and health insurers all along the political spectrum, but with all the money Big Pharma spends on lobbying, will Washington take up drug pricing reform?
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?
Trump plays scolder-in-chief with NATO allies At the opening of NATO’s dramatic new headquarters in Brussels today, President Trump acknowledged that Article 5 — promising that “an attack on one nation is an attack on all” -- has only been invoked one time: in the aftermath of September 11. But the President failed to provide what 27 other Alliance members have been waiting for: a re-commitment by America’s new leader to Article 5. Instead, they got a scolding.
Trump's new look at civil rights and global warming President Trump is reportedly ready to pull the US out of the Paris Agreement on Climate Change. We look at the possible consequences. On the second half of the program, we hear about cuts in Obama-Era civil rights programs called for by the Trump Administration's first budget plan.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.